The medtech developer exceeded Wall Street expectations across the board, reporting $19.5 billion in revenue for fiscal year ...

At the TCT conference in San Diego, Medtronic and Recor Medical presented new findings from their rival treatments for high ...

Smith+Nephew’s CEO confirmed this week that talks failed with Johnson & Johnson over an orthopedic megamerger with DePuy ...

The Vitalyst system is a miniature heart pump designed to treat acute myocardial infarction cardiogenic shock.

The trial found earlier interventions with Edwards’ Sapien 3 TAVR implant brought fewer heart failure-related events after two years.

Flow Medical expects a first-in-human case "very soon" and an IDE submission in 2027, co-founder and CEO Jennifer Fried tells ...

The study at the TCT conference in San Diego showed Boston Scientific's Watchman FLX Pro could allow for simpler blood ...

Shareholders of Siemens and Siemens Healthineers will vote on the deconsolidation from Siemens during their annual meetings ...

The annual TCT conference in San Diego saw medtechs illustrate methods for controlling stroke, reestablishing coronaries and ...

Abbott’s next-gen Oncodetect molecular residual disease (MRD) test detects traces of circulating tumor DNA in a patient’s ...

CEO Mike Mahoney said the upcoming years will be a time of restructuring for Boston Scientific, following layoffs and ...

Philips has reached a settlement with the Department of Justice to tie up the remaining criminal and civil probes into its ...